Author | Danielle Ternyila

Articles

Immunotherapy-Based Combos May be Necessary in Neuroendocrine Neoplasms

May 22, 2020

Article

The immune checkpoint inhibitor induced 1 objective response but appeared safe as treatment of patients with metastatic high-grade neuroendocrine neoplasms in 2 open-label phase 2 clinical trials.

Trending News on Targeted Oncology, Week of May 22, 2020

May 22, 2020

Article

Targeted Oncology reviews trending news online for the week of May 22, 2020, including recent news from the FDA, updates in oncology, and new information regarding COVID-19.

FDA Approves Brigatinib as Frontline Treatment of ALK-Positive Metastatic NSCLC

May 22, 2020

Article

The FDA has granted approval to brigatinib for the frontline treatment of patients with ALK-positive metastatic non–small cell lung cancer, as detected by an FDA-approved test.

Trastuzumab Deruxtecan Receives Orphan Drug Designation from FDA for Gastric Cancer

May 22, 2020

Article

Fam-trastuzumab deruxtecan-nxki has received an Orphan Drug designation for the treatment of patients with gastric or gastroesophageal junction cancer.